Stemz Oncology Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 07-07-2024
- Paid Up Capital ₹ 0.10 M
as on 07-07-2024
- Company Age 8 Year, 5 Months
- Last Filing with ROC 31 Mar 2022
- Revenue %
(FY 2022)
- Profit -479.57%
(FY 2022)
- Ebitda -947.27%
(FY 2022)
- Total Assets -96.65%
(FY 2022)
About Stemz Oncology
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Raman Sodhi and Aman Bakhshi serve as directors at the Company.
- CIN/LLPIN
U74999HR2016PTC065047
- Company No.
065047
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jul 2016
- Date of AGM
12 Aug 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Gurgaon, Haryana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Stemz Oncology?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raman Sodhi  | Director | 18-Jul-2016 | Current |
| Aman Bakhshi | Director | 15-Apr-2019 | Current |
Financial Performance and Corporate Structure Insights of Stemz Oncology.
Stemz Oncology Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 479.57% decrease in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Stemz Oncology?
In 2020, Stemz Oncology had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Stemz Radiology Private LimitedActive 8 years 5 monthsRaman Sodhi and Aman Bakhshi are mutual person
Stemz Healthcare Private LimitedActive 9 years 2 monthsRaman Sodhi and Aman Bakhshi are mutual person
Nd Diagnostics India Private LimitedActive 19 years 6 monthsRaman Sodhi and Aman Bakhshi are mutual person
- Stemztech Industries Private LimitedActive 3 years 8 months
Raman Sodhi and Aman Bakhshi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Stemz Oncology?
Unlock and access historical data on people associated with Stemz Oncology, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Stemz Oncology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stemz Oncology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
